198 related articles for article (PubMed ID: 35894142)
21. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
22. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
23. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract][Full Text] [Related]
24. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
Li KS; Zhu XD; Liu HD; Zhang SZ; Li XL; Xiao N; Liu XF; Xu B; Lei M; Zhang YY; Shi WK; Cao MQ; Xu YF; Tang ZY; Sun HC
Cell Death Dis; 2020 May; 11(5):335. PubMed ID: 32382041
[TBL] [Abstract][Full Text] [Related]
25. ICT1 predicts a poor survival and correlated with cell proliferation in diffuse large B-cell lymphoma.
Xie W; Wu M; Fu T; Li X; Wang Z; Hu Y; Zhu L; Zhang G
Gene; 2017 Sep; 627():255-262. PubMed ID: 28629825
[TBL] [Abstract][Full Text] [Related]
26. Anticancer effect of quinacrine on diffuse large B‑cell lymphoma via inhibition of MSI2‑NUMB signaling pathway.
Yang S; Sheng L; Xu K; Wang Y; Zhu H; Zhang P; Mu Q; Ouyang G
Mol Med Rep; 2018 Jan; 17(1):522-530. PubMed ID: 29115587
[TBL] [Abstract][Full Text] [Related]
27. miR‑29b suppresses proliferation and induces apoptosis of hepatocellular carcinoma ascites H22 cells via regulating TGF‑β1 and p53 signaling pathway.
Liu YL; Yang WH; Chen BY; Nie J; Su ZR; Zheng JN; Gong ST; Chen JN; Jiang D; Li Y
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34184070
[TBL] [Abstract][Full Text] [Related]
28. A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway.
Lu K; Li B; Zhang H; Xu Z; Song D; Gao L; Sun H; Li L; Wang Y; Feng Q; Chen G; Hu L; Wei R; Xie Y; Yu D; Wu X; Zhu W; Shi J
Signal Transduct Target Ther; 2020 Apr; 5(1):31. PubMed ID: 32296013
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
30. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
[TBL] [Abstract][Full Text] [Related]
31. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
[TBL] [Abstract][Full Text] [Related]
32. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
Liu W; Lei L; Liu X; Ye S
Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
[TBL] [Abstract][Full Text] [Related]
33. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
[TBL] [Abstract][Full Text] [Related]
34. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
Huang Y; Lin Y; Song X; Wu D
Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
[TBL] [Abstract][Full Text] [Related]
35. Andrographolide Induces G2/M Cell Cycle Arrest and Apoptosis in Human Glioblastoma DBTRG-05MG Cell Line via ERK1/2 /c-Myc/p53 Signaling Pathway.
Othman NS; Mohd Azman DK
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235222
[TBL] [Abstract][Full Text] [Related]
36. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
37. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
Ding T; Hao J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-377-3p promotes cell proliferation and inhibits cell cycle arrest and cell apoptosis in hepatocellular carcinoma by affecting EGR1-mediated p53 activation.
Li W; Li K; Wang Z; Fa Z
Pathol Res Pract; 2022 Jun; 234():153855. PubMed ID: 35461040
[TBL] [Abstract][Full Text] [Related]
39. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
[TBL] [Abstract][Full Text] [Related]
40. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]